Business & investing: With its share price up 42 percent year-to-date as well as achieving more than two decades of unbroken revenue growth, AFT Pharmaceuticals probably ranks as one of this year’s most underrated local success stories. “By the standards of the global pharmaceutical industry, AFT is a small company. Dr Hartley Atkinson, AFT’s managing director and co-founder, told Newsroom the company’s recent performance, which included revenue growth of 22 percent and operating profit up 39 percent, reflected a strategic plan focused on maintaining growth. We’ve made a significant investment in growing the business over the last few years, which is now coming to fruition. Atkinson remains upbeat and is expecting to further extend AFT’s record for continual revenue growth in the current financial year – despite the uncertainties in the global trading environment.